Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Nevirapine and Saquinavir-sgc in HIV
NCT02184286Phase 1Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- May 1999
- Primary completion
- Feb 2000
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of nevirapine in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Primary endpoints: Maximum observed concentration at Day 28, Time of maximum concentration at Day 28 and 3 more. Started May 1999; status: terminated.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02184286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184286.